Xie C - Search Results

1

Cancer type classification using plasma cell-free RNAs derived from human and microbes.

Chen S, Jin Y, Wang S, Xing S, Wu Y, Tao Y, Ma Y, Zuo S, Liu X, Hu Y, Chen H, Luo Y, Xia F, Xie C, Yin J, Wang X, Liu Z, Zhang N, Zech Xu Z, Lu ZJ, Wang P. Chen S, et al. Among authors: xie c. Elife. 2022 Jul 11;11:e75181. doi: 10.7554/eLife.75181. Elife. 2022. PMID: 35816095 Free PMC article.

2

FBXW10 promotes hepatocarcinogenesis in male patients and mice.

Luo YD, Zhang J, Fang L, Zhu YY, You YM, Zhang CC, Zheng P, Zhang LD, Yin LY, Xia F, Bie P, Xie CM. Luo YD, et al. Carcinogenesis. 2020 Jul 10;41(5):689-698. doi: 10.1093/carcin/bgz138. Carcinogenesis. 2020. PMID: 31400758

3

Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma.

Luo YD, Yu HQ, Liu XY, Huang D, Dai HS, Fang L, Zhang YJ, Lai JJ, Jiang Y, Shuai L, Zhang LD, Chen G, Bie P, Xie CM. Luo YD, et al. Cancer Med. 2020 Jun;9(12):4083-4094. doi: 10.1002/cam4.3040. Epub 2020 Apr 15. Cancer Med. 2020. PMID: 32293796 Free PMC article.

4

Reduced IκBα promotes hepatocellular carcinoma cell proliferation and migration via regulation of NF-κB/Erbin axis.

Tan Y, Lin XT, Luo YD, Zhang J, Fang L, Zhu YY, Yu HQ, Shuai L, Jiang Y, Zhang LD, Bie P, Xie CM. Tan Y, et al. Oncol Lett. 2020 Nov;20(5):216. doi: 10.3892/ol.2020.12079. Epub 2020 Sep 9. Oncol Lett. 2020. PMID: 32963622 Free PMC article.

5

Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation.

Lin XT, Yu HQ, Fang L, Tan Y, Liu ZY, Wu D, Zhang J, Xiong HJ, Xie CM. Lin XT, et al. Elife. 2021 Nov 15;10:e70715. doi: 10.7554/eLife.70715. Elife. 2021. PMID: 34779401 Free PMC article.

6

Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling.

Luo YD, Liu XY, Fang L, Yu HQ, Zhang YJ, Chen M, Zhang LD, Xie CM. Luo YD, et al. Theranostics. 2022 Nov 16;12(18):7903-7919. doi: 10.7150/thno.76873. eCollection 2022. Theranostics. 2022. PMID: 36451866 Free PMC article.

7

Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice.

Zhang J, Lin XT, Yu HQ, Fang L, Wu D, Luo YD, Zhang YJ, Xie CM. Zhang J, et al. Exp Mol Med. 2023 Oct;55(10):2162-2176. doi: 10.1038/s12276-023-01060-7. Epub 2023 Sep 1. Exp Mol Med. 2023. PMID: 37653031 Free PMC article.

8

Author Correction: Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice.

Zhang J, Lin XT, Yu HQ, Fang L, Wu D, Luo YD, Zhang YJ, Xie CM. Zhang J, et al. Exp Mol Med. 2023 Oct;55(10):2281-2286. doi: 10.1038/s12276-023-01116-8. Exp Mol Med. 2023. PMID: 37783772 Free PMC article. No abstract available.

9

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.

Luo YD, Fang L, Yu HQ, Zhang J, Lin XT, Liu XY, Wu D, Li GX, Huang D, Zhang YJ, Chen S, Jiang Y, Shuai L, He Y, Zhang LD, Bie P, Xie CM. Luo YD, et al. J Hepatol. 2021 Jan;74(1):96-108. doi: 10.1016/j.jhep.2020.07.036. Epub 2020 Jul 29. J Hepatol. 2021. PMID: 32738450 Free article.

10

Integrated ubiquitomics characterization of hepatocellular carcinomas.

Lin XT, Luo YD, Mao C, Gong Y, Hou Y, Zhang LD, Gu YP, Wu D, Zhang J, Zhang YJ, Tan DH, Xie CM. Lin XT, et al. Among authors: xie cm. Hepatology. 2024 Sep 30. doi: 10.1097/HEP.0000000000001096. Online ahead of print. Hepatology. 2024. PMID: 39348425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,280 results

Search Page

Filters